Sci Show: While cannabidiol (CBD), the non-psychoactive substance derived from cannabis, reduces pain in animals, its ability to do so in humans is limited by low bioavailability. A new study suggests this may be overcome by a novel CBD analog which reduced pain sensitivity and opioid cravings in mice.

Sunday, May 9, 2021

While cannabidiol (CBD), the non-psychoactive substance derived from cannabis, reduces pain in animals, its ability to do so in humans is limited by low bioavailability. A new study suggests this may be overcome by a novel CBD analog which reduced pain sensitivity and opioid cravings in mice.

https://ift.tt/3eZMoBu via /r/science https://ift.tt/3w79fCb

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)